American Association for Cancer Research (AACR), a scientific society
of over 17,000 laboratory and clinical cancer researchers, was founded
in 1907 to facilitate communication and dissemination of knowledge
among scientists and others dedicated to the cancer problem; to foster
research in cancer and related biomedical sciences; to encourage presentation
and discussion of new and important observations in the field; to
foster public education, science education, and training; and to advance
the understanding of cancer etiology, prevention, diagnosis, and treatment
throughout the world.
the ECSU labs are working on the role of tyrosine kinase inhibitors
and other novel therapeutic agents on treatment of the brain cancer
Astrocytoma. Visiting the AACR 2002 annual meeting at San Francisco,
CA allowed them to experience and learn about the current progress
in cancer therapy, diagnosis and epidemiology. For a brief description
of the meeting and coverage of the major events go to AACR
93rd Annual Meeting Report.